Histone deacetylase inhibitor, Trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells
2006

Trichostatin A and Cyclin D1 Degradation in Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): John P. Alao, Alexandra V. Stavropoulou, Eric W-F Lam, Charles Coombes, David M. Vigushin

Primary Institution: Imperial College, Hammersmith Hospital

Hypothesis

Does the histone deacetylase inhibitor trichostatin A induce degradation of cyclin D1 in MCF-7 breast cancer cells?

Conclusion

Trichostatin A induces rapid degradation of cyclin D1 in MCF-7 cells through a GSK3β-mediated pathway.

Supporting Evidence

  • Trichostatin A treatment leads to the rapid degradation of cyclin D1 in MCF-7 cells.
  • GSK3β-mediated phosphorylation is necessary for cyclin D1 degradation.
  • Inhibition of the proteasome prevents cyclin D1 degradation induced by trichostatin A.

Takeaway

A drug called trichostatin A helps get rid of a protein called cyclin D1 in breast cancer cells, which can help stop the cancer from growing.

Methodology

The study used MCF-7 breast cancer cells to investigate the effects of trichostatin A on cyclin D1 degradation, employing various inhibitors and mutagenesis techniques.

Limitations

The study does not fully explore the alternative pathways for cyclin D1 degradation independent of GSK3β.

Digital Object Identifier (DOI)

10.1186/1476-4598-5-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication